# Contact Script Semaglutide: Editorial Corrections and Source Notes

> Contact Script Semaglutide — for editorial corrections and source notes on our semaglutide research summaries. We do not provide medical advice or sell any product.

Corrections, source notes, and editorial questions.

## What to write about

Contact Script Semaglutide for editorial matters: a correction to a summary, a question about a citation, a newer study you think belongs in the record, or a note about how a finding is framed. We take accuracy seriously and update the log when the literature warrants it.

We cannot answer personal medical questions, recommend or adjust a dose, or advise on whether semaglutide is right for anyone. We are an editorial publisher, not a clinic, and we do not provide care of any kind.

## What we can't help with

We do not sell, source, supply, or recommend any product, including compounded semaglutide, and we cannot connect anyone to a prescriber or pharmacy. Messages asking where to buy a product, requesting a prescription, or seeking individual dosing guidance will not receive that information, because providing it is outside what this site does. For your own health decisions, please speak with a qualified clinician who can review your situation.

## Editorial contact

Use the form below to reach the editorial desk. Please include the page and the bracketed citation number if your note is about a specific claim, so we can trace it quickly. We read every message about the accuracy of the record.

---

A terminal-clean log of the semaglutide trial record — the STEP, SELECT, SUSTAIN-6 and FLOW figures committed to source, the emerging alcohol-craving lines flagged as early, and the unconfirmed signals left in plain view; no clinic behind the console, no script written, and nothing here dosed, compounded, or sold.